Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,549 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04987203 | Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma | completed | Phase 3 | 343 | AVEO Pharmaceuticals, Inc.INDUSTRY | 16 | May 8, 2026 | clinicaltrials |
| NCT05114746 | Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan | completed | Phase 2 | 94 | Novartis PharmaceuticalsINDUSTRY | 1 | May 8, 2026 | clinicaltrials |
| NCT07462403 | A Prolonged Nightly Fasting for Men on ADT for PCa | completed | N/A | 40 | Thomas Jefferson UniversityOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT03229083 | Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma | completed | N/A | 21 | University of RochesterOTHER | 1 | May 7, 2026 | clinicaltrials |
| NCT02535533 | SLM + Axitinib for Clear Cell RCC | completed | Phase 1 / Phase 2 | 45 | Mohammed MilhemOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT03123978 | Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 6 | University of California, DavisOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04565457 | A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality | completed | N/A | 43 | University of Colorado, DenverOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04726319 | Family History App in Personalized Medicine(FHAMe) | completed | N/A | 627 | University of TorontoOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT06575361 | Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis | completed | N/A | 365 | Peking University First HospitalOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07568444 | Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3) | completed | Phase 2 | 120 | University of Southern CaliforniaOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT05005728 | XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 2 | 72 | Xencor, Inc.INDUSTRY | 1 | May 5, 2026 | clinicaltrials |
| NCT05409872 | Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids(DEFIB) | completed | N/A | 108 | Universita di VeronaOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07567573 | Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery(retroESGO ov1) | completed | — | 11,383 | European Society of Gynaecological OncologyOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT03797326 | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) | completed | Phase 2 | 611 | Merck Sharp & Dohme LLCINDUSTRY | 17 | May 4, 2026 | clinicaltrials |
| NCT04739527 | Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment(ALISON) | completed | Phase 1 | 17 | University Medical Center GroningenOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT07561502 | Transurethral Periprostatectomy Treatment of Cancerous Prostate Tissue(PERI III) | completed | N/A | 32 | Francis Medical Inc.INDUSTRY | 1 | May 1, 2026 | clinicaltrials |
| NCT06661044 | Understanding the Benefits of Dietary Fibre Supplementation in Patients With Prostate Cancer(EVENTIDE) | completed | — | 6 | University of AberdeenOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT02649855 | Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer | completed | Phase 2 | 74 | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2026 | clinicaltrials |
| NCT03218826 | PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 23 | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2026 | clinicaltrials |
| NCT04558398 | Impact of Exercise on Mitochondria in Cancer Patients.(ICCE-Mito) | completed | N/A | 15 | University of NottinghamOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT07547267 | The Effect of Vaginal Dilator Use | completed | N/A | 80 | Istanbul Aydın UniversityOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT02121730 | Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy Regions(FRISC) | completed | — | 2,500 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT04185389 | Long-Term Follow-Up of HPV FOCAL Participants(HPV FOCAL) | completed | — | 1,710 | University of British ColumbiaOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT05133440 | A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones | completed | Phase 2 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT05156268 | A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma | completed | Phase 2 | 26 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT06104449 | A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) | completed | Phase 1 | 7 | Merck Sharp & Dohme LLCINDUSTRY | 1 | Apr 27, 2026 | clinicaltrials |
| NCT04305925 | Focal Laser Ablation of Prostate Cancer | completed | Early Phase 1 | 10 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT04716127 | A Proximity-incentive Strategy for Cervical Cancer Screening(RIDECA) | completed | N/A | 656 | University Hospital, MontpellierOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT04943380 | Efficacy and Utility of Cxbladder Tests in Hematuria Patients(DRIVE) | completed | — | 682 | Pacific Edge LimitedINDUSTRY | 1 | Apr 24, 2026 | clinicaltrials |
| NCT05033067 | The Personal Patient Profile Decision Support for Patients With Bladder Cancer(P3BC) | completed | N/A | 24 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT06059014 | Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer(PRadR) | completed | Phase 1 / Phase 2 | 6 | Centre Leon BerardOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT02104362 | Single Fraction Early Prostate Irradiation (SiFEPI)(SiFEPI) | completed | N/A | 35 | Centre Antoine LacassagneOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT04925648 | Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction(PICASSO) | completed | Phase 2 | 4 | St Vincent's Hospital, SydneyOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT02109367 | Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass | completed | — | 52 | Southern Illinois UniversityOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT03556839 | Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix(BEATcc) | completed | Phase 3 | 410 | Grupo Español de Investigación en Cáncer de OvarioOTHER | 8 | Apr 21, 2026 | clinicaltrials |
| NCT06138496 | Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC | completed | Phase 2 | 39 | Sun Yat-sen UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT02695121 | Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment | completed | — | 2,133,575 | AstraZenecaINDUSTRY | 3 | Apr 17, 2026 | clinicaltrials |
| NCT03732768 | Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis | completed | Phase 1 | 21 | Oncoinvent Solutions ASINDUSTRY | 3 | Apr 17, 2026 | clinicaltrials |
| NCT06610474 | Evaluation of an Online Prostate Cancer Screening Decision Aid | completed | N/A | 88 | David SiegelFED | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07219134 | Pilot Investigation of Dual Energy CT Imaging on an Online Adaptive Radiation Therapy System | completed | — | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07533344 | Ga-68 PSMA PET/CT vs mpMRI in Cognitive Prostate Biopsy(PSMA-MRI BX) | completed | — | 60 | Fatih Sultan Mehmet Training and Research HospitalOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT00814021 | Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain | completed | Phase 2 | 21 | Institut Claudius RegaudOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT01868087 | Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study | completed | Early Phase 1 | 30 | Jill Hamilton-Reeves, PhD RD LDOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT04028245 | A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma(SPARC-1) | completed | Early Phase 1 | 17 | Columbia UniversityOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT05489978 | Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal | completed | N/A | 310 | Kathmandu University School of Medical SciencesOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT01902680 | Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.(CURIEFOCALE) | completed | Phase 2 | 18 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT02854215 | Cost Utility of Radical Surgery in Ovarian Cancer(CURSOC) | completed | N/A | 200 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT01982786 | Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer | completed | N/A | 57 | Canadian Cancer Trials GroupNETWORK | 1 | Apr 13, 2026 | clinicaltrials |
| NCT02225704 | Radium-223 in Combination With Enzalutamide | completed | Phase 2 | 45 | Cancer Trials IrelandNETWORK | 1 | Apr 13, 2026 | clinicaltrials |
| NCT02772588 | AASUR in High Risk Prostate Cancer | completed | Phase 2 | 64 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 13, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 8, 2026source: clinicaltrials